Xermelo

Xermelo (telotristat ethyl) is an oral medication used to manage symptoms associated with carcinoid syndrome diarrhea. It works by reducing serotonin production to help control frequent bowel movements. This overview covers key uses, effects, precautions, and interactions for informed use. Short-term symptom support for diarrhea related to carcinoid tumors.

Xermelo (telotristat ethyl) is primarily used to reduce the number of bowel movements in people with carcinoid syndrome diarrhea. Carcinoid syndrome occurs when neuroendocrine tumors release excess serotonin, leading to symptoms like diarrhea and flushing. This medication helps manage these symptoms by lowering serotonin levels. It is often prescribed alongside other treatments for carcinoid tumors.

Xermelo (telotristat ethyl) may help reduce the frequency of diarrhea episodes in patients with carcinoid syndrome. Some users report improved comfort and fewer urgent bowel movements. Effects can vary, and it may take time to notice changes in symptoms. It does not cure carcinoid tumors but aims to manage associated diarrhea.

Xermelo should be taken exactly as prescribed by a healthcare provider. It is important to discuss your full medical history, including liver conditions, before starting this medication. Regular monitoring may be recommended to assess its effectiveness and safety. Avoid sudden changes in dosage without professional guidance.

Xermelo can interact with medications that affect liver enzymes, such as certain antidepressants or antifungals. Combining it with alcohol may increase side effects like dizziness or drowsiness. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments or monitoring.